Avadel Pharmaceuticals Stock Options
| AVDL Stock | USD 10.00 0.15 1.48% |
Avadel Pharmaceuticals' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 1.07 with a put-to-call open interest ratio of 1.13 over 17 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on 2024-12-20. The total put volume is at 303, with calls trading at the volume of 303. This yields a 4.39 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
2024-12-20
The chart above shows Avadel Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Avadel Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Avadel Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Avadel Pharmaceuticals
Analyzing Avadel Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Avadel Pharmaceuticals regardless of its overall volatility. This is especially true when Avadel Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Avadel Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Avadel Pharmaceuticals' stock while costing only a fraction of its price.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Avadel Pharmaceuticals In The Money Call Balance
When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying Avadel Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Avadel Pharmaceuticals PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Avadel Current Options Market Mood
Avadel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Avadel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Avadel Pharmaceuticals' options investors are not very successful. Avadel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Avadel contract
Base on the Rule 16, the options market is currently suggesting that Avadel Pharmaceuticals PLC will have an average daily up or down price movement of about 0.0669% per day over the life of the 2024-12-20 option contract. With Avadel Pharmaceuticals trading at USD 10.0, that is roughly USD 0.006688. If you think that the market is fully incorporating Avadel Pharmaceuticals' daily price movement you should consider buying Avadel Pharmaceuticals PLC options at the current volatility level of 1.07%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Avadel |
Purchasing Avadel Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Avadel calls. Remember, the seller must deliver Avadel Pharmaceuticals PLC stock to the call owner when a call is exercised.
Avadel Pharmaceuticals Option Chain
When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Avadel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Avadel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Avadel. It also shows strike prices and maturity days for a Avadel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | AVDL Option Call 20-12-2024 7 | 0 | 2024-12-20 | 0.0 - 0.0 | 3.58 | In |
Call | AVDL Option Call 20-12-2024 10 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.32 | |
Call | AVDL Option Call 20-12-2024 12 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 15 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 17 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.1 | |
Call | AVDL Option Call 20-12-2024 20 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.05 | |
Call | AVDL Option Call 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.08 | |
Call | AVDL Option Call 20-12-2024 25 | 69 | 2024-12-20 | 0.0 - 0.35 | 0.4 | Out |
Call | AVDL Option Call 20-12-2024 30 | 3 | 2024-12-20 | 0.0 - 0.75 | 0.3 | Out |
Call | AVDL Option Call 20-12-2024 35 | 19 | 2024-12-20 | 0.0 - 1.0 | 0.3 | Out |
Put | AVDL Option Put 20-12-2024 7 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.1 | |
Put | AVDL Option Put 20-12-2024 10 | 0 | 2024-12-20 | 0.0 - 0.0 | 0.35 | |
Put | AVDL Option Put 20-12-2024 12 | 0 | 2024-12-20 | 0.0 - 0.0 | 2.6 | In |
Put | AVDL Option Put 20-12-2024 15 | 0 | 2024-12-20 | 0.0 - 0.0 | 5.07 | In |
Put | AVDL Option Put 20-12-2024 17 | 3 | 2024-12-20 | 7.1 - 7.6 | 2.05 | In |
Put | AVDL Option Put 20-12-2024 20 | 100 | 2024-12-20 | 5.3 - 7.1 | 5.6 | In |
Put | AVDL Option Put 20-12-2024 22 | 0 | 2024-12-20 | 0.0 - 0.0 | 8.7 | In |
Avadel Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Avadel Total Stockholder Equity
Total Stockholder Equity |
|
Avadel Pharmaceuticals Corporate Management
| Gregory Davis | VP Development | Profile | |
| Richard Kim | Chief Officer | Profile | |
| Christian PharmD | Chief Affairs | Profile | |
| Steven Sullivan | VP Operations | Profile | |
| Jason Vaughn | Senior Operations | Profile | |
| Jennifer PharmD | Senior Affairs | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.